Systemic delivery of recombinant proteins by genetically modified myoblasts.
about
Antigen processing and presentation by a murine myoblast cell linePreclinical assessment of wt GNE gene plasmid for management of hereditary inclusion body myopathy 2 (HIBM2)Kinetics of recombinant adeno-associated virus-mediated gene transfer.DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model.Differentiation and long-term survival of C2C12 myoblast grafts in heart.Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade.Targeted expression of transforming growth factor-beta 1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis.Myoblast transfer of human erythropoietin gene in a mouse model of renal failureGene transfer into mammalian somatic cells in vivo.Experimental and clinical applications of molecular cell biology in nutrition and metabolism.Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus.Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic proteinIn vivo transfer and expression of a human epidermal growth factor gene accelerates wound repairTransient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibersDynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source.Systemic immunological effects of cytokine genes injected into skeletal muscle.IGF-I increases bone marrow contribution to adult skeletal muscle and enhances the fusion of myelomonocytic precursors.Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes.Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapyGene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivoPlasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model.Advances in musculoskeletal tissue engineering: moving towards therapy.Intramuscular delivery of rat kallikrein-binding protein gene reverses hypotension in transgenic mice expressing human tissue kallikrein.Chicken adenovirus (CELO virus) particles augment receptor-mediated DNA delivery to mammalian cells and yield exceptional levels of stable transformants.Can a few good cells now mend a broken heart?A self-immunomodulating myoblast cell line for erythropoietin delivery.Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapy.Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubesEffect of growth factors and extracellular matrix materials on the proliferation and differentiation of microencapsulated myoblasts.Ovine adenovirus vectors mediate efficient gene transfer to skeletal muscle.Autologous, orthotopic thyroid follicular cell transplantation: a surgical component of ex vivo somatic gene therapy.Skeletal myogenesis on elastomeric substrates: implications for tissue engineering.
P2860
Q27473532-52EFE624-F6AA-4B13-9222-B64F4FC20555Q30489819-97D8C80F-6A51-452A-8EFD-D75E384186DCQ33802149-B5B30D7C-5654-45A2-A7BA-4B073E8239A2Q33842956-5F506673-BDD3-464F-B38A-C4367A3A18CEQ33903190-62673505-DDEC-43C1-BAE2-796B42811225Q34191737-27D7C8D5-3669-4037-88AB-0BCB9307DCE7Q34193341-16CA596C-707A-4F80-B0EB-05AC3B9076BEQ34210746-2C7D085D-ABBD-4663-BA4E-E6DA97DA920EQ35369781-5A812958-14A0-45F0-84F6-2BE1E2117295Q35526805-59C13100-F8D7-4887-AEEC-0208512263CDQ35922620-6E8BC227-D3D9-42CC-BBE0-E0B63AD43A8EQ35943644-56D6EF26-F54B-4CDE-8054-205513047F38Q35966236-F15830AF-182B-41A2-8841-1A2CDF45DED4Q36234961-98F78B07-5E8F-47A1-B5BF-9A0165DA2003Q36293384-EF1BB438-6236-4420-AE94-40F29A49B6E8Q36302958-68F94D85-4FC4-4282-BEFC-96390AE99314Q36320501-1788ADCD-0D16-4EA1-95AD-A1ADD33D32BAQ36438020-B26BE78B-1CBE-45CF-AE5A-3440A9EE0AA4Q36534906-DA1807F6-68B9-439F-92A5-DBA025AB4AD0Q37300317-764EF722-999C-4C43-9531-0C56BDE9561DQ37383110-7454A5E8-B7A1-4825-B8B8-5B7225777754Q37825415-11228B46-F99A-4A30-8530-90CC3EC5CA57Q38299884-28F0BA3F-828E-4C5C-B094-7140946F08A9Q40045754-750C9156-FA3D-41C1-B93E-953CC222EECDQ40304769-2FBDBA95-5EC9-4D55-A2E4-83F9D6F0B8A8Q40799718-AF8B7F1F-0D77-45E4-B1E7-B2CAFD73F7C2Q40890770-C9E8BCC7-BE42-4EC9-A707-9C6373D52F5CQ41876376-8CD46133-E40B-452C-BE25-84E1000A7E91Q44538771-BEBAFC8E-0978-4106-AF72-84FB44A7E0E7Q45871061-0794D228-622E-421F-946C-31A516ED167EQ45874723-D815B4F6-E14F-4130-9A05-658D55BAE49FQ47758042-BCDFF357-AFA1-40CD-B1D9-D7F02D6EC9B8
P2860
Systemic delivery of recombinant proteins by genetically modified myoblasts.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Systemic delivery of recombinant proteins by genetically modified myoblasts.
@en
type
label
Systemic delivery of recombinant proteins by genetically modified myoblasts.
@en
prefLabel
Systemic delivery of recombinant proteins by genetically modified myoblasts.
@en
P356
P1433
P1476
Systemic delivery of recombinant proteins by genetically modified myoblasts.
@en
P2093
P304
P356
10.1126/SCIENCE.1962212
P407
P577
1991-12-01T00:00:00Z